Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$98.98 - $115.74 $217,459 - $254,280
-2,197 Reduced 14.78%
12,664 $1.47 Million
Q2 2023

Aug 10, 2023

BUY
$96.34 - $112.38 $349,232 - $407,377
3,625 Added 32.26%
14,861 $1.53 Million
Q1 2023

May 11, 2023

SELL
$107.32 - $113.5 $1.51 Million - $1.59 Million
-14,041 Reduced 55.55%
11,236 $1.23 Million
Q4 2022

Feb 02, 2023

BUY
$62.39 - $113.8 $9,732 - $17,752
156 Added 0.62%
25,277 $2.88 Million
Q3 2022

Nov 04, 2022

SELL
$58.92 - $84.67 $67,522 - $97,031
-1,146 Reduced 4.36%
25,121 $1.56 Million
Q2 2022

Aug 01, 2022

SELL
$79.4 - $116.36 $158,006 - $231,556
-1,990 Reduced 7.04%
26,267 $2.1 Million
Q1 2022

May 10, 2022

SELL
$86.42 - $109.81 $253,469 - $322,072
-2,933 Reduced 9.4%
28,257 $2.97 Million
Q4 2021

Feb 08, 2022

SELL
$98.56 - $119.91 $536,166 - $652,310
-5,440 Reduced 14.85%
31,190 $3.36 Million
Q3 2021

Nov 12, 2021

SELL
$91.91 - $110.37 $159,096 - $191,050
-1,731 Reduced 4.51%
36,630 $4.01 Million
Q2 2021

Aug 12, 2021

BUY
$86.24 - $95.92 $2.3 Million - $2.56 Million
26,715 Added 229.39%
38,361 $3.59 Million
Q1 2021

May 14, 2021

SELL
$71.83 - $95.48 $242,929 - $322,913
-3,382 Reduced 22.5%
11,646 $1.07 Million
Q4 2020

Feb 09, 2021

BUY
$67.0 - $84.39 $117,116 - $147,513
1,748 Added 13.16%
15,028 $1.1 Million
Q3 2020

Nov 13, 2020

SELL
$55.23 - $79.93 $243,453 - $352,331
-4,408 Reduced 24.92%
13,280 $1.03 Million
Q2 2020

Aug 03, 2020

BUY
$30.2 - $56.98 $66,983 - $126,381
2,218 Added 14.34%
17,688 $983,000
Q1 2020

May 15, 2020

SELL
$24.87 - $38.56 $3,581 - $5,552
-144 Reduced 0.92%
15,470 $458,000
Q4 2019

Feb 18, 2020

BUY
$25.43 - $36.67 $47,859 - $69,012
1,882 Added 13.71%
15,614 $565,000
Q3 2019

Nov 12, 2019

SELL
$23.0 - $27.97 $68,310 - $83,070
-2,970 Reduced 17.78%
13,732 $374,000
Q2 2019

Aug 13, 2019

BUY
$22.81 - $28.48 $380,972 - $475,672
16,702 New
16,702 $402,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.